Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Source BioScience acquires Cambridge Clinical Laboratories

Cambridge, UK, 10 April 2025: Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL), a leading Cambridge-based provider of clinical, personalised healthcare testing services. The acquisition bolsters the Company’s clinical diagnostics portfolio by leveraging the expertise of the CCL team and new state-of-the-art clinical lab facilities at Vision Park in Cambridge, providing streamlined testing services for both preclinical and clinical research.

Coulter Partners strengthens leadership at iOnctura with placement of Board Chair

London, April 10, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for iOnctura and is pleased to announce the placement of Dr. Mark Velleca as Chair of the Board of Directors.

iOnctura is a clinical-stage precision oncology company combating neglected and hard-to-treat cancers with a pipeline of first-in-class small molecules.

Cancer Research Horizons partners with Histofy to develop AI-based tools for the personalised treatment of colorectal cancer

Cancer Research Horizons, the innovation arm of Cancer Research UK, has announced a collaboration with Histofy, a leader in AI-driven histopathology solutions, to develop tools that predict how colorectal cancer patients respond to different treatment options using the multi-modal S:CORT dataset.

Measuring the Return From Pharmaceutical Innovation: Be Brave, Be Bold New Insights & Webinar Invitation

Research and development innovation is the lifeblood of the pharmaceutical sector but in a highly competitive market returns are hard won. Our 15th annual detailed analysis, in Measuring the return from pharmaceutical innovation: Be brave, be bold, shows an upward trajectory with the IRR increasing from 4.3% in 2023 to 5.9% in 2024. This positive trend is driven largely by new high-value blockbuster assets entering the late-stage pipeline, particularly for therapies addressing obesity, menopause, Alzheimer’s, and other unmet needs.

Cambridge Opens Its Doors: A Week of Innovation at the Home of UK Life Sciences

The buzzing Cambridge Wide Open annual event returns in June, this time as a week-long interactive festival showcasing Cambridge’s pioneers, the companies of the future, and opening the offices and workspaces that make up one of the world’s most vibrant ecosystems.

Building on the momentum of the last two Cambridge Wide Open Days, the event will run from 9 - 13th June 2025, offering an immersive experience to global investors, ecosystem CEO’s and employees, sci-tech enthusiasts, policymakers, academics, and curious residents alike.

Postdoc Fellow in Cancer Inequities

The Cortes-Ciriano group studies the mutational processes and mechanisms of genome instability underpinning tumourigenesis, immune escape, and drug response through the analysis of high-throughput sequencing data from clinical samples. The group is also leading the development of novel approaches for early cancer detection using long-read sequencing. More information about the group can be found here.

Your role

Postdoctoral Fellow

The Cortes-Ciriano group studies the mutational processes and mechanisms of genome instability underpinning tumourigenesis, immune escape, and drug response through the analysis of high-throughput sequencing data from clinical samples. The group is also leading the development of novel approaches for early cancer detection using long-read sequencing. More information about the group can be found here.

Your role

Subscribe to